Dimethyl Sulfoxide NDC 84897-052

NDC codes

FDA NDC Directory

Product NDC (as listed)84897-052Labeler and product segments. Claims need a package NDC.

Product NDC at billing width84897-0052Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
84897-052-01	84897005201	1 VIAL, GLASS in 1 CARTON (84897-052-01) / 50 mL in 1 VIAL, GLASSMarketed from Dec 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dimethyl Sulfoxide
Generic name (nonproprietary): dimethyl sulfoxide
Active ingredients: Dimethyl sulfoxide — .54 g/mL
Dosage form: Irrigant
Route: Intravesical
Labeler: Renova Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220173
Marketing start: Dec 1, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 84897-052_135af82c-ec68-4d72-a882-22e662c2f38aSPL ID 135af82c-ec68-4d72-a882-22e662c2f38aSPL set ID 8f699de6-9d09-48da-9d95-4001d7008587RxCUI 562359UNII YOW8V9698HUPC 0384897052015

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N484897005201 followed by a unit qualifier and the quantity

Package 84897-0052-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 20, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dimethyl sulfoxide is indicated for the symptomatic relief of patients with interstitial cystitis. Dimethyl sulfoxide has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)